Abametapir and Thiotepa: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jun 30, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Abametapir
No brand names on recordThiotepa
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Abametapir is a lotion used to treat head lice. Even though it goes on your scalp, a little can get into your body and briefly block a liver enzyme called CYP3A4 that helps break down many other medicines.
Thiotepa is a chemotherapy medicine that your body clears using that same enzyme. If the enzyme is blocked, thiotepa could build up higher than expected, which may raise the risk of side effects. This concern is based on how the drugs work rather than on real-world reports, but because thiotepa is a serious cancer drug, doctors take it seriously. The good news: your care team can plan the timing and manage this safely, so talk with them before using both.
Mechanism: Abametapir is a CYP3A4 inhibitor; thiotepa is a CYP3A4 substrate. Inhibition can decrease thiotepa clearance, increasing systemic exposure (AUC/Cmax) and toxicity risk.
- Direction: Increased thiotepa exposure and effect.
- Onset: Rapid; enzyme inhibition persists for up to ~2 weeks after a single topical application.
- Evidence: Theoretical, based on abametapir's known CYP3A4 inhibition.
- Severity: Major, given thiotepa's cytotoxic profile and narrow safety margin.
Management: Avoid CYP3A4 substrates, including thiotepa, within 2 weeks after abametapir application. If concomitant use is unavoidable, avoid abametapir. Coordinate timing and monitoring through the oncology team.
What happens
Increased exposure of CYP3A4 substrate
Interaction Deep Dive
For a period of 2 weeks following the use of abametapir, CYP3A4 substrates should not be administered. When that is not possible, abametapir itself should be avoided 1.
Why it happens (mechanism)
Inhibition of CYP3A4-mediated metabolism by abametapir
How to manage this interaction
Both medicines are important, so the goal is safe timing rather than stopping treatment on your own.
- Keep taking your prescribed chemotherapy and do not start or stop anything without your team.
- Tell your oncology team and pharmacist before using abametapir lice lotion, since its effect on the liver enzyme can last about 2 weeks.
- Your care team will typically separate the timing (avoid the lotion within 2 weeks of thiotepa) or choose a different lice treatment if needed.
- They may also monitor you more closely for chemotherapy side effects if both are used.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Abametapir and Thiotepa together?
Abametapir can raise thiotepa levels by blocking CYP3A4, so avoid using the lice lotion within 2 weeks of thiotepa; let your oncology team coordinate timing or pick an alternative. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Abametapir and Thiotepa interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "rapid". Effects can appear quickly, often within about 24 hours of combining the drugs.
How is the Abametapir and Thiotepa interaction managed?
Both medicines are important, so the goal is safe timing rather than stopping treatment on your own. Keep taking your prescribed chemotherapy and do not start or stop anything without your team. Tell your oncology team and pharmacist before using abametapir lice lotion, since its effect on the liver enzyme can last about 2 weeks. Your care team will typically separate the timing (avoid the lotion… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Abametapir or Thiotepa need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: XEGLYZE(TM) topical lotion, abametapir topical lotion. Dr Reddy’s Laboratories Inc (per FDA), Princeton, NJ, 2020. DailyMed
Keep reading about Abametapir
Keep reading about Thiotepa
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist